Ocular Manifestations

  • Vincenzo Petitti
  • Stefano Tamburi
Part of the Updates in Surgery book series (UPDATESSURG)


Crohn’s disease (CD), or regional enteritis, is a segmentary granulomatous inflammatory bowel pathology of unknown etiology although autoimmunity is probably involved. In addition, there are extraintestinal manifestations, such as arthritis, cutaneous lesions, and hepatic, renal, and ocular involvement. The incidence of the latter, manifested as uveitis, scleritis, and episcleritis, is about 2–9% of the cases of CD [1, 2, 3, 4]. Moreover, 30–40% of patients with scleritis also have a systemic autoimmune disease, such as rheumatoid arthritis, Wegener granulomatosis, and inflammatory bowel disease (IBD) [5], and 2% of patients with uveitis may develop IBD; indeed uveitis may even precede IBD onset. Nearly 40% of patients with IBD-associated uveitis are positive for HLA B27. Arthritis in CD may develop os peripheral arthropathies or as ankylosing spondylitis. Among the latter, nearly 70% are HLA-B27 positive and 50% of the patients in this group develop ocular involvement, mainly uveitis. In addition to these immunological pathologies in patients with CD, an infection of the eye, mycotic endophthalmitis, may develop as a complication in patients receiving parenteral nutrition to treat malabsorption or following bowel surgery.


Inflammatory Bowel Disease Cystoid Macular Edema Anterior Uveitis Systemic Autoimmune Disease Ocular Involvement 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hopkins DJ, Horan E, Burton IL et al (1974) Ocular disorders in a series of 332 patients with Crohn’s disease. Br J Ophthalmol 58:732–737CrossRefPubMedGoogle Scholar
  2. 2.
    Mintz R, Feller FR, Bahr RL, Shah SA (2004) Ocular manifestations in inflammatory bowel disease. Inflamm Bowel Dis 10:135–139CrossRefPubMedGoogle Scholar
  3. 3.
    Yilmaz S, Aydemir E, Maden A, Unsal B (2007) The prevalence of ocular involvement in patients with inflammatory bowel disease. Int J Colorectal Dis 22:1027–1030CrossRefPubMedGoogle Scholar
  4. 4.
    Knox DL, Schachat AP, Mustonen E (1984) Primary, secondary and coincidental ocular complications of Crohn’s Disease. Ophthalmology 91:163–173PubMedGoogle Scholar
  5. 5.
    Lin P, Bhullar SS, Tessler HH, Goldstein DA (2008) Immunologic markers as potential predictors of systemic autoimmune disease in patients with idiopathic scleritis. Am J Ophthalmol 45:463–471CrossRefGoogle Scholar
  6. 6.
    McCluskey PJ, Wakefield D (1995) Scleritis and episcleritis. In: Pepose JS, Holland GN, Wilhelmus KR (eds) Ocular infection & immunity Mosby, St Louis, Missouri, pp 642–662Google Scholar
  7. 7.
    Pivetti Pezzi P (1987) Le flogosi uveali. Masson Italia Editore, MilanGoogle Scholar
  8. 8.
    Pettit TH, Edwards JE, Purdy EP, Bullock JD (1995) Endogenous fungal endophthalmitis. In: Pepose JS, Holland GN and Wilhelmus KR (eds) Ocular infection & immunity. Mosby, St Louis, Missouri, pp 1262–1285Google Scholar
  9. 9.
    Pivetti Pezzi P, Tamburi S, Bozzoni F et al (1992) Endoftalmite micotica endogena: possibilità limiti attuali della terapie farmacologica. Boll Ocul 2:255–264Google Scholar

Copyright information

© Springer-Verlag Italia 2010

Authors and Affiliations

  • Vincenzo Petitti
    • 1
  • Stefano Tamburi
    • 1
  1. 1.Opthalmology Unit, Department of Head and NeckSan Camilo-Forlanini HospitalRomeItaly

Personalised recommendations